Ningbo Nuoze Pharmaceutical

Ningbo Nuoze Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and manufacturing of inhalation medications for respiratory diseases. The company leverages its proprietary inhalation drug delivery platform to develop high-barrier complex generics and innovative drugs, including Dry Powder Inhalers (DPI), Metered-Dose Inhalers (MDI), and nebulized solutions. Its primary therapeutic focus is on chronic obstructive pulmonary disease (COPD) and asthma, with a pipeline that includes several advanced-stage candidates. Nuoze Pharmaceutical operates GMP-compliant manufacturing facilities designed to meet international standards, aiming to provide high-quality respiratory treatments for both domestic and global markets.